Banerjee Ahana, Singh Prerna, Sheikh Parvaiz A, Kumar Ashok, Koul Veena, Bhattacharyya Jayanta
Centre for Biomedical Engineering, Indian Institute of Technology Delhi, New Delhi-110016, India; Department of Biomedical Engineering, All India Institute of Medical Science, Delhi, New Delhi-110029, India.
Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kalyanpur, Kanpur, Uttar Pradesh-208016, India; Centre for Environmental Science and Engineering, Indian Institute of Technology Kanpur, Kalyanpur, Kanpur, Uttar Pradesh-208016, India.
Int J Biol Macromol. 2024 Jun;270(Pt 2):132384. doi: 10.1016/j.ijbiomac.2024.132384. Epub 2024 May 14.
The impairment of phenotype switching of pro-inflammatory M1 to pro-healing M2 macrophage induced by hyperglycemic microenvironment often elevates oxidative stress, impairs angiogenesis, and leads to chronic non-healing wounds in diabetic patients. Administration of M2 macrophage-derived exosomes (M2Exo) at wound site is known to polarize M1 to M2 macrophage and can accelerate wound healing by enhancing collagen deposition, angiogenesis, and re-epithelialization. In the present study, M2Exo were conjugated with oxidized hyaluronic acid and mixed with PEGylated silk fibroin to develop self-healing Exo-gel to achieve an efficient therapy for diabetic wounds. Exo-gel depicted porous networked morphology with self-healing and excellent water retention behaviour. Fibroblast cells treated with Exo-gel showed significant uptake of M2Exo that increased their proliferation and migration in vitro. Interestingly, in a diabetic wound model of wistar rats, Exo-gel treatment induced 75 % wound closure within 7 days with complete epithelial layer regeneration by modulating cytokine levels, stimulating fibroblast-keratinocyte interaction and migration, angiogenesis, and organized collagen deposition. Taken together, this study suggests that Exo-gel depict properties of an excellent wound healing matrix and can be used as a therapeutic alternative to treat chronic non-healing diabetic wounds.
高血糖微环境诱导促炎M1巨噬细胞向促愈合M2巨噬细胞表型转换受损,常导致氧化应激增加、血管生成受损,并引发糖尿病患者慢性难愈合伤口。已知在伤口部位施用M2巨噬细胞衍生的外泌体(M2Exo)可使M1巨噬细胞极化为M2巨噬细胞,并可通过增强胶原蛋白沉积、血管生成和再上皮化来加速伤口愈合。在本研究中,将M2Exo与氧化透明质酸偶联,并与聚乙二醇化丝素蛋白混合,以开发自愈合外泌体凝胶,实现对糖尿病伤口的有效治疗。外泌体凝胶呈现出具有自愈合和优异保水性能的多孔网络形态。用外泌体凝胶处理的成纤维细胞显示出对M2Exo的显著摄取,这增加了它们在体外的增殖和迁移。有趣的是,在Wistar大鼠的糖尿病伤口模型中,外泌体凝胶治疗在7天内诱导75%的伤口闭合,并通过调节细胞因子水平、刺激成纤维细胞与角质形成细胞的相互作用和迁移、血管生成以及有序的胶原蛋白沉积实现完全上皮层再生。综上所述,本研究表明外泌体凝胶具有优异的伤口愈合基质特性,可作为治疗慢性难愈合糖尿病伤口的替代疗法。